Dianthus Therapeutics's total assets for Q3 2024 were $354.25M, a decrease of -3.99% from the previous quarter. DNTH total liabilities were $16.35M for the fiscal quarter, a 52.22% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.